Today, the shares of Dottikon, a Swiss chemicals company focusing on exclusive synthesis, were traded in the main segment of the SWX Swiss Exchange for the first time. Dottikon ES Holding AG is a spin-off of the Ems chemicals group. The newly created shares were offered to existing shareholders with subscription rights. The subscription rights were traded on the SWX from 23 March through 29 March. The equity's issue price, determined on the basis of rights trading, was CHF 189. The opening price on the SWX today was CHF 200. This corresponds to a market capitalisation of CHF 255 million. Dottikon ES Holding AG belongs not only to the SPI®, but also to the SPI EXTRA®.
According to the listing prospectus, of the 1,272,644 registered shares entered in the Commercial Register, more than 40 % are publicly held. 1,252,644 of the placed shares proceed from a capital increase connected with the IPO.
Dottikon ES is a Swiss-based fine chemical company specialising in hazardous, safety-critical chemical reactions. It is focused on the exclusive synthesis of fine chemicals and provides custom manufacturing for major pharmaceutical and industrial companies around the world.
Dottikon ES currently employs about 400 people. In 2004, the company generated a turnover of CHF 118 million and a net profit of CHF 12.1 million.
